German court overturns kava ban

By Shane STARLING contact

- Last updated on GMT

Related tags: Germany

German court overturns kava ban
Germany’s 12-year ban on calming herb kava is, “unlawful and inappropriate” the country’s Federal Administrative Court has found.

Kava toxicity fears spread at the beginning of the 2000s after adverse event reports linking it to liver problems and many countries warned against it in the EU and elsewhere like the US.

But the German court found the risks were not high enough to justify the ban and overturned it.

Kava, aqueous extracts from the roots of Piper methysticum,​ recently received a boost when University of Minnesota researchers used a proprietary blend to identify kava components​ that showed anti-cancer activity in mice.

The German ruling (in German) can be found here.

Related news

Show more

Related products

show more

Reach Consumers with Fruit & Vegetable Powders

Reach Consumers with Fruit & Vegetable Powders

vaneeghen | 08-Sep-2021 | Technical / White Paper

Are you looking to create products that appeal to today’s plant-forward consumers? The plant-based revolution continues to captivate the market as consumers...

COGNIGRAPE™ GRAPE EXTRACT FOR COGNITIVE HEALTH

COGNIGRAPE™ GRAPE EXTRACT FOR COGNITIVE HEALTH

BIONAP Srl | 07-Sep-2021 | Product Brochure

COGNIGRAPE™ is a standardized solid extract obtained from a Sicilian grape variety. Thanks to the high content of ANTHOCYANINS and PROANTHOCYANIDINS, COGNIGRAPE™...

Turmacin®: Clean Label & Clinically Tested Turmeric

Turmacin®: Clean Label & Clinically Tested Turmeric

Natural Remedies Private Limited | 01-Sep-2021 | Product Presentation

Turmacin® is a clean label project-certified, clinically tested, and clinically safe turmeric extract. Turmacin® is rich in Turmerosaccharides® and doesn't...

How to Enter UK’s £690M CBD Market

How to Enter UK’s £690M CBD Market

The Association for the Cannabinoid Industry | 18-Jun-2021 | Technical / White Paper

The UK has the world’s most developed regulatory framework for legal cannabinoids, such as CBD and CBG. With a 2021 market estimated to be worth £690 million...

Related suppliers

Follow us

Products

View more

Webinars